Peter Sorantin

Peter Sorantin, Ph.D., is an accomplished business development and commercial strategy veteran. He brings 25 years of high stakes experience in the R&D sector of the pharmaceutical and healthcare industry with targeted focus on strategic innovation. His expertise includes novel digital outcome measurements and data collection systems designed for CNS clinical trials and therapeutics. Peter’s science background and his customer relationships allow him to develop a clear understanding of unmet industry needs and to be a thought and business leader in the rapidly evolving digital market segment of clinical outcomes.